Catalio Capital Management, LP Cytokinetics Inc Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Catalio Capital Management, LP holds 585,812 shares of CYTK stock, worth $21.2 Million. This represents 5.73% of its overall portfolio holdings.
Number of Shares
585,812
Previous 457,587
28.02%
Holding current value
$21.2 Million
Previous $21.5 Billion
9.38%
% of portfolio
5.73%
Previous 4.71%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$531 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$428 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$360 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$289 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$220 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.4B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...